Severe infusion-related reaction to crizanlizumab in an adolescent with sickle cell disease. Karkoska K, Quinn CT, Clapp K, McGann PT, et al. Am J Hematol 2020;95:E338-E339.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Karkoska K, Quinn CT, Clapp K, McGann PT, et al. Severe infusion-related reaction to crizanlizumab in an adolescent with sickle cell disease. Am J Hematol 2020;95:E338-E339.
PMID: 32945013